AI Science Tracker

Proteomic profiling and machine learning identified an externally validated diagnostic panel and severity markers for infective endocarditis

Fudan University; Guangdong Provincial People's Hospital/Southern Medical University; Fuwai Hospital/Chinese Academy of Medical Sciences; collaborating hospitals in China · 30 May 2025 · medicine

Discovery

Proteomic profiling and machine learning identified an externally validated diagnostic panel and severity markers for infective endocarditis

The study profiled plasma and excised vegetation samples from 238 infective-endocarditis patients and 100 controls, then used an ensemble machine-learning pipeline to select a 10-protein plasma diagnostic panel. The paper reports AUCs of 0.97 in the held-out discovery test set and 0.98 and 0.94 in two external plasma cohorts. Integrating proteomic and clinical features also produced a prognostic model for severe heart-failure status (abstract AUC 0.87). LRG1 and NDUFB4 were associated with infection severity in the cohort analyses.

Technology: Ensemble machine-learning diagnostic and prognostic models; the diagnostic workflow compared six algorithms and used recursive feature elimination with cross-validation to select a 10-protein panel

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: The paper reports AUCs of 0.97 in the held-out discovery test set and 0.98 and 0.94 in two external plasma cohorts.
  • Still unknown: The study is an observational proteomic cohort analysis; it does not demonstrate that use of the panel improves patient outcomes or can replace current diagnostic criteria. The development comparison included 238 IE patients and 100 controls, so case-control separation may not reflect performance in an unselected real-world diagnostic population. External evaluation used two additional plasma cohorts (combined n=328); the prognostic endpoint and biomarkers are associations, not causal mechanisms. The paper's proposed NET-related therapeutic implications are hypothesis-generating and are not counted as demonstrated treatment benefit.
  • AI role: Machine-learning feature-importance analysis and recursive feature elimination selected a 10-protein plasma combination for distinguishing infective endocarditis from non-endocarditis samples. The models were evaluated in a held-out discovery cohort and two external plasma cohorts. A separate model combined proteomic and clinical features to classify severe heart-failure status.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/40447567/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 10 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.